Latest News about CRSP
Recent news which mentions CRSP
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
December 15, 2023
From InvestorPlace
After This Landmark Win, Is CRISPR Therapeutics a Buy?
December 15, 2023
From Motley Fool
3 Small-Cap Stocks That Could Skyrocket 1000% by 2030
December 14, 2023
From InvestorPlace
Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock
December 14, 2023
From InvestorPlace
1 Biotech Stock That Could Be the Next Amgen
December 13, 2023
From Motley Fool
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
December 13, 2023
From Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
From InvestorPlace
Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam
December 12, 2023
From Benzinga
Could Intellia Therapeutics Become the Next CRISPR Therapeutics?
December 12, 2023
From Motley Fool
Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails
December 11, 2023
From Benzinga
Why CRISPR Stock Keeps Falling
December 11, 2023
From Motley Fool
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
December 11, 2023
From InvestorPlace
HP To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Monday
December 11, 2023
From Benzinga
From Motley Fool
The 3 Best Cathie Wood Stocks to Buy in December
December 10, 2023
From InvestorPlace
From Motley Fool
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
December 08, 2023
From Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
From MarketWatch
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?
December 08, 2023
From Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
From InvestorPlace
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics
December 07, 2023
From Motley Fool
5 Unstoppable Trends to Invest $1,000 in for 2024
December 07, 2023
From Motley Fool
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
From InvestorPlace
Is This News a Setback or a Step Forward for CRISPR Therapeutics?
December 06, 2023
Tickers
CRSP
From Motley Fool
Here's How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
December 06, 2023
Tickers
CRSP
From Benzinga
CRISPR Therapeutics' Gene-Edited Oncology Pipeline To Focus On Expanded Use In Autoimmune Diseases
December 05, 2023
Tickers
CRSP
From Benzinga
Better Growth Stock: CRISPR Therapeutics vs. Invitae
December 05, 2023
From Motley Fool
The Market's Up This Year. Do You Feel Like You Are Winning?
December 04, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.